MedPath

Oracit

ORACIT Oral Citrate (Shohl's) SolutionCMP Pharma, Inc.

Approved
Approval ID

bc26abed-8e6e-475d-8ab3-abf7d0377003

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 7, 2023

Manufacturers
FDA

CMP Pharma, Inc.

DUNS: 005224175

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Citric Acid and Sodium Citrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code46287-014
Product Classification
G
Generic Name
Citric Acid and Sodium Citrate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 2, 2020
FDA Product Classification

INGREDIENTS (5)

CITRIC ACID MONOHYDRATEActive
Quantity: 640 mg in 5 mL
Code: 2968PHW8QP
Classification: ACTIM
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
TRISODIUM CITRATE DIHYDRATEActive
Quantity: 490 mg in 5 mL
Code: B22547B95K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oracit - FDA Drug Approval Details